CLINICAL_TRIALS
trial_result
· 2021-03-22
Clinical Trial Update: A Prospective Study of Tocilizumab in the Treatment of Idiopathic Retroperitoneal Fibrosis [Phase 4]
Summary
A Phase 4 clinical trial update evaluating tocilizumab for idiopathic retroperitoneal fibrosis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Peking Union Medical College Hospital | Conditions: Idiopathic Retroperitoneal Fibrosis | Phase 4 | Status: UNKNOWN